BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NIN, KIAA1565, 51199, ENSG00000100503
5 results:

  • 1. Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment.
    Wu J; Guo J; Fang Q; Liu Y; Li C; Xie W; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1131693. PubMed ID: 37522128
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes.
    Pyle LC; Kim J; Bradfield J; Damrauer SM; D'Andrea K; Einhorn LH; Godse R; Hakonarson H; Kanetsky PA; Kember RL; Jacobs LA; Maxwell KN; Rader DJ; Vaughn DJ; Weathers B; Wubbenhorst B; Regeneron Genetics Center Research Team ; Cancer Genomics Research Laboratory ; Greene MH; Nathanson KL; Stewart DR
    Eur Urol; 2024 Apr; 85(4):337-345. PubMed ID: 37246069
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.
    Jang JH; Cotterchio M; Borgida A; Liu G; Gallinger S; Cleary SP
    Mol Carcinog; 2013 Nov; 52 Suppl 1(0 1):E103-9. PubMed ID: 23908141
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells.
    Lin Y; Peng S; Yu H; Teng H; Cui M
    Med Oncol; 2012 Mar; 29(1):311-7. PubMed ID: 21287298
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
    Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.